PT567. Improvement to antipsychotic treatment at week 2 predicts subsequent treatment response in behavioral and psychological symptoms with dementia: Analysis of the CATIE-AD data
نویسندگان
چکیده
s | 9 PT566 A survey of medication using antipsychotics in patients with dementia. Takumi Shimizu, Showa University Northern Yokohama Hospital,
منابع مشابه
PT594. Placebo effects in Alzheimer Disease: analysis of the CATIE-AD data
s | 19 Results: Aβ+ aMCI individuals (relative to Aβ-) showed faster decline in paired associates learning (PAL) (p=0.02, ES=0.4) over 12 months. Aβ+ aMCI individuals who were APOE ɛ4 carriers (compared to noncarriers) had a greater decline in PAL (p<0.01, ES=0.6). No other cognitive domain including attention and executive function were affected by Aβ positivity and/or APOE ɛ4 carriage. Concl...
متن کاملAdjunctive treatment with high frequency repetitive transcranial magnetic stimulation for the behavioral and psychological symptoms of patients with Alzheimer's disease: a randomized, double-blind, sham-controlled study
BACKGROUND Behavioral and psychological symptoms of dementia (BPSD) occur in 70-90% of patients at different stages of Alzheimer's Disease (AD), but the available methods for managing these problems are of limited effectiveness. AIM Assess the effects of high-frequency repetitive transcranial magnetic stimulation (rTMS), applied over the left dorsolateral prefrontal cortex (DLPFC), on BPSD an...
متن کاملPT596. The comparison with galantamine and donepezil on Alzheimer’s Disease patients and its relationship with cerebral blood flow
s | 19 Results: Aβ+ aMCI individuals (relative to Aβ-) showed faster decline in paired associates learning (PAL) (p=0.02, ES=0.4) over 12 months. Aβ+ aMCI individuals who were APOE ɛ4 carriers (compared to noncarriers) had a greater decline in PAL (p<0.01, ES=0.6). No other cognitive domain including attention and executive function were affected by Aβ positivity and/or APOE ɛ4 carriage. Concl...
متن کاملPT595. Incidence and course of depression in Alzheimer’s disease patients
s | 19 Results: Aβ+ aMCI individuals (relative to Aβ-) showed faster decline in paired associates learning (PAL) (p=0.02, ES=0.4) over 12 months. Aβ+ aMCI individuals who were APOE ɛ4 carriers (compared to noncarriers) had a greater decline in PAL (p<0.01, ES=0.6). No other cognitive domain including attention and executive function were affected by Aβ positivity and/or APOE ɛ4 carriage. Concl...
متن کاملEvaluation of the efficacy and safety of pregabalin as an adjuvant to antipsychotics in patients with chronic schizophrenia: a six-week pilot double-blind placebo-controlled trial
Introduction and objectives: Antipsychotics or dopamine receptor antagonists are the major components of treatment but about 10-20% of patients with schizophrenia do not benefit from treatment with antidopaminergic agents, indicating other neuronal systems may be involved in this disorder (2). Dysregulation of both excitatory and inhibitory mechanisms N-Methyl-D-aspartic acid (NMDA) and γ-Amino...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 19 شماره
صفحات -
تاریخ انتشار 2016